Beate Wieseler

2.6k total citations
36 papers, 1.5k citations indexed

About

Beate Wieseler is a scholar working on Economics and Econometrics, Statistics, Probability and Uncertainty and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Beate Wieseler has authored 36 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Economics and Econometrics, 10 papers in Statistics, Probability and Uncertainty and 8 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Beate Wieseler's work include Health Systems, Economic Evaluations, Quality of Life (17 papers), Meta-analysis and systematic reviews (10 papers) and Pharmaceutical industry and healthcare (8 papers). Beate Wieseler is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (17 papers), Meta-analysis and systematic reviews (10 papers) and Pharmaceutical industry and healthcare (8 papers). Beate Wieseler collaborates with scholars based in Germany, United Kingdom and United States. Beate Wieseler's co-authors include Thomas Kaiser, Natalie McGauran, Ulrich Grouven, Julia Kreis, Heike Kölsch, M Kerekeş, Mandy Kromp, Dirk Eyding, Martin Härter and Joachim Szécsényi and has published in prestigious journals such as The Lancet, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Beate Wieseler

35 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Beate Wieseler Germany 20 489 297 284 203 170 36 1.5k
Jeppe Bennekou Schroll Denmark 16 331 0.7× 290 1.0× 328 1.2× 434 2.1× 143 0.8× 38 1.7k
Mette T. Haahr Denmark 9 543 1.1× 963 3.2× 494 1.7× 250 1.2× 215 1.3× 10 1.9k
Natalie McGauran Germany 15 319 0.7× 235 0.8× 257 0.9× 129 0.6× 114 0.7× 24 937
Spencer Phillips Hey United States 21 479 1.0× 99 0.3× 268 0.9× 44 0.2× 213 1.3× 68 1.5k
Eugenia Cronin United Kingdom 4 242 0.5× 494 1.7× 275 1.0× 73 0.4× 144 0.8× 6 1.1k
Hwanhee Hong United States 24 131 0.3× 211 0.7× 121 0.4× 56 0.3× 68 0.4× 103 2.8k
Vance W. Berger United States 19 357 0.7× 328 1.1× 121 0.4× 37 0.2× 76 0.4× 76 1.4k
Bennett Levitan United States 20 530 1.1× 44 0.1× 94 0.3× 119 0.6× 265 1.6× 80 1.3k
Hamilton Moses United States 17 447 0.9× 133 0.4× 453 1.6× 227 1.1× 352 2.1× 33 1.5k
Emily R. Cox Australia 20 610 1.2× 21 0.1× 171 0.6× 159 0.8× 183 1.1× 56 1.5k

Countries citing papers authored by Beate Wieseler

Since Specialization
Citations

This map shows the geographic impact of Beate Wieseler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beate Wieseler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beate Wieseler more than expected).

Fields of papers citing papers by Beate Wieseler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Beate Wieseler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beate Wieseler. The network helps show where Beate Wieseler may publish in the future.

Co-authorship network of co-authors of Beate Wieseler

This figure shows the co-authorship network connecting the top 25 collaborators of Beate Wieseler. A scholar is included among the top collaborators of Beate Wieseler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Beate Wieseler. Beate Wieseler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
King‐Kallimanis, Bellinda L., Melanie Calvert, David Cella, et al.. (2023). Perspectives on Patient-Reported Outcome Data After Treatment Discontinuation in Cancer Clinical Trials. Value in Health. 26(10). 1543–1548. 2 indexed citations
4.
Wieseler, Beate & Natalie McGauran. (2020). From publication bias to lost in information: why we need a central public portal for clinical trial data. BMJ evidence-based medicine. 27(2). 74–76. 4 indexed citations
5.
Naci, Huseyin, Maximilian Salcher‐Konrad, Aaron S. Kesselheim, et al.. (2020). Generating comparative evidence on new drugs and devices before approval. The Lancet. 395(10228). 986–997. 52 indexed citations
6.
Wieseler, Beate, Natalie McGauran, & Thomas Kaiser. (2019). New drugs: where did we go wrong and what can we do better?. BMJ. 366. l4340–l4340. 73 indexed citations
7.
Köhler, Michael & Beate Wieseler. (2018). Why clinical study reports really matter. Medical Writing. 27. 59–63.
8.
Sturtz, Sibylle, et al.. (2016). Assumptions of Mixed Treatment Comparisons in Health Technology Assessments - Challenges and Possible Steps for Practical Application. PLoS ONE. 11(8). e0160712–e0160712. 17 indexed citations
9.
McGauran, Natalie, et al.. (2014). Impact of Inclusion of Industry Trial Results Registries as an Information Source for Systematic Reviews. PLoS ONE. 9(4). e92067–e92067. 16 indexed citations
10.
McGauran, Natalie, et al.. (2014). Early benefit assessment of new drugs in Germany – Results from 2011 to 2012. Health Policy. 116(2-3). 147–153. 25 indexed citations
11.
Teljeur, Conor, et al.. (2014). ENDPOINTS FOR RELATIVE EFFECTIVENESS ASSESSMENT (REA) OF PHARMACEUTICALS. International Journal of Technology Assessment in Health Care. 30(5). 508–513. 10 indexed citations
12.
Wieseler, Beate, et al.. (2013). Completeness of Reporting of Patient-Relevant Clinical Trial Outcomes: Comparison of Unpublished Clinical Study Reports with Publicly Available Data. PLoS Medicine. 10(10). e1001526–e1001526. 91 indexed citations
14.
15.
Wieseler, Beate & Natalie McGauran. (2010). Reporting a Systematic Review. CHEST Journal. 137(5). 1240–1246. 23 indexed citations
16.
Wieseler, Beate, Natalie McGauran, & Thomas Kaiser. (2010). Finding studies on reboxetine: a tale of hide and seek. BMJ. 341(oct12 1). c4942–c4942. 22 indexed citations
17.
Wieseler, Beate. (2010). Ergebnisregister für klinische Studien – ein Meilenstein auf dem Weg zur Transparenz klinischer Forschung?. Zeitschrift für Evidenz Fortbildung und Qualität im Gesundheitswesen. 104(4). 298–305. 1 indexed citations
18.
Koller, Michael, Max Augustin, Arndt Büssing, et al.. (2009). Die Erfassung von Lebensqualität in der Versorgungsforschung – konzeptuelle, methodische und strukturelle Voraussetzungen. Das Gesundheitswesen. 71(12). 864–872. 55 indexed citations
19.
Neiss, A, et al.. (2002). Complications, co-morbidity, and blood glucose control in type 2 diabetes mellitus patients in Germany - results from the CODE-2TM study. Experimental and Clinical Endocrinology & Diabetes. 110(1). 10–16. 68 indexed citations
20.
Wieseler, Beate & Matthias Müller. (1993). Translocation of precytochrome C2 into intracytoplasmic membrane vesicles of Rhodobacter capsulatus requires a peripheral membrane protein. Molecular Microbiology. 7(2). 167–176. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026